Friday, May 27, 2022

Did Corona come from a US bioweapons lab in Ukraine?

 

coronavirus biolabs Ukraine research bioweapons biowarfare military

On April 13, 2022, British investigative website The Exposé published evidence that the Covid-19 virus originated in US bioweapons laboratories.

The authors first noticed an entry on the US government website USA Spending. This referred to a grant from the Ministry of Defense for an explicitly designated “Covid-19 research” project in Kiev on November 12, 2019. However, the world only became aware of the disease two days into 2020, and the virus was allegedly only named on February 11, 2020.

“The sub-contract was awarded 12 November 2019, at least one month before the alleged emergence of the novel Coronavirus, and three months before it was officially dubbed Covid-19, the award for Covid-19 research should come as a shock to everyone,” the authors highlighted.

As early as 2012, according to USA Spending, the ministry had begun to generously support the American company Black & Veatch Special Projects Corp for a “Program to Reduce Biological Risks in Ukraine“. The money was used in over 100 sub-projects and some of the funds were explicitly forwarded “to Kiev” for setting up laboratories – one of the recipients seven years later was the aforementioned COVID project of the US company Labyrinth Global Health Inc.

As early as 2009, its boss Karen Saylors worked on a Coronavirus program of the US government agency USAID alongside the organization EcoHealth Alliance (EHA). In early 2020 EHA was one of the most important protagonists of the global Covid system. It also became Labyrinth’s primary partner in the new Kiev project – as did the company Metabiota of Nathan Wolfe, who was previously the lead virologist at the US Department of Defense.

Wolfe, incidentally was one of the “Young Global Leaders” of the so-called World Economic Forum, closely associated with global schemes to bring about a Great Reset.  (more...)

Did Corona come from a US bioweapons lab in Ukraine?


No comments:

Post a Comment